Docstoc

2012 Aarkstore.com | QLT Inc. – Product Pipeline Review – 2012

Document Sample
2012 Aarkstore.com | QLT Inc. – Product Pipeline Review – 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

QLT Inc. – Product Pipeline Review – 2012



You can also request for sample page of above mention reports on
sample@aarkstore.com




Summary

Global Market Direct’s pharmaceuticals report, “QLT Inc. - Product Pipeline Review -
2012” provides data on the QLT Inc.’s research and development focus. The report
includes information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, QLT Inc.’s corporate website, SEC filings, investor
presentations and featured press releases, both from QLT Inc. and industry-specific
third party sources, put together by Global Markets Direct’s team.

Scope

- QLT Inc. - Brief QLT Inc. overview including business description, key information
and facts, and its locations and subsidiaries.
- Review of current pipeline of QLT Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.

Table of contents:

List of Tables 4
List of Figures 5
QLT Inc. Snapshot 6
QLT Inc. Overview 6
Key Information 6
Key Facts 6
QLT Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
QLT Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
QLT Inc. – Pipeline Products Glance 12
QLT Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
QLT Inc. – Drug Profiles 14
Latanoprost Punctal Plug Delivery System 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Lemuteporfin 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
QLT091001 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Visudyne + Lucentis + Dexamethasone 19
Product Description 19
Mechanism of Action 19



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1




Paladin Labs Inc. – Product Pipeline Review – 2012

Pharmos Corporation – Product Pipeline Review – 2012

POZEN Inc. – Product Pipeline Review – 2012

QLT Inc. – Product Pipeline Review – 2012

Shire Plc – Product Pipeline Review – 2012

Paladin Labs Inc. – Product Pipeline Review – 2012

Pharmos Corporation – Product Pipeline Review – 2012

POZEN Inc. – Product Pipeline Review – 2012

QLT Inc. – Product Pipeline Review – 2012

Shire Plc – Product Pipeline Review – 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:4
posted:8/31/2012
language:English
pages:4
Description: Global Market Direct’s pharmaceuticals report, “QLT Inc. - Product Pipeline Review - 2012” provides data on the QLT Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.